Living Cell Technologies Limited (LVCLF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.52 Million | -1.98 Million | -2.04 Million | -1.46 Million | -3.1 Million | -1.99 Million |
| Net Income | -2.09 Million | -2.1 Million | -1.95 Million | -1.46 Million | -968.46 Thousand | -3.18 Million |
| Depreciation & Amortization | - | 557.00 | 743.00 | 49.31 Thousand | 70.94 Thousand | 52.29 Thousand |
| Deferred income taxes | - | 1250.00 | 44.7 Thousand | 47.43 Thousand | -20.1 Thousand | -126.66 Thousand |
| Stock-based compensation | 764.53 Thousand | -1250.00 | -44.7 Thousand | -47.43 Thousand | 20.1 Thousand | 126.66 Thousand |
| Change in working capital | -34.76 Thousand | 99.4 Thousand | -41.9 Thousand | 101.28 Thousand | -982.33 Thousand | 964.11 Thousand |
| Other non-cash items | -157.5 Thousand | 21.4 Thousand | -43.74 Thousand | -151.52 Thousand | -1.22 Million | 174.42 Thousand |
| Investing Cash Flow | -277.44 Thousand | - | 39.49 Thousand | 105.85 Thousand | 1.23 Million | -53.31 Thousand |
| Investments in PPE | - | - | -3803.00 | - | - | -53.31 Thousand |
| Acquisitions | - | - | - | - | 91.77 Thousand | -42.99 Thousand |
| Investment purchases | -3.3 Million | - | - | - | - | - |
| Sales/Maturities of investments | 3.02 Million | - | 43.3 Thousand | 105.85 Thousand | 1.14 Million | - |
| Other Investing Activities | -277.44 Thousand | - | 43.3 Thousand | 105.85 Thousand | 1.23 Million | 42.99 Thousand |
| Financing Cash Flow | 522.99 Thousand | 1.85 Million | 4.68 Million | -44.53 Thousand | -50.24 Thousand | - |
| Debt repayment | - | - | -2.28 Million | -44.53 Thousand | -50.24 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 572.25 Thousand | 1.85 Million | 2.85 Million | - | - | - |
| Other Financing Activities | -49.26 Thousand | -299.06 Thousand | 1.82 Million | -44.53 Thousand | -50.24 Thousand | - |
| Accounts receivables | 53.14 Thousand | -66.19 Thousand | -16.07 Thousand | 94.26 Thousand | 379.67 Thousand | -183.5 Thousand |
| Accounts payables | -180.01 Thousand | 156.07 Thousand | 27.24 Thousand | -28.28 Thousand | -1.35 Million | 1.13 Million |
| Inventory | - | - | -1.00 | - | - | - |
| Other working capital | -87.9 Thousand | 9521.00 | -53.06 Thousand | 35.3 Thousand | -8443.00 | 10.32 Thousand |
| Cash at beginning of period | 2.08 Million | 4.23 Million | 1.56 Million | 2.96 Million | 4.9 Million | 6.86 Million |
| Cash at end of period | 808.41 Thousand | 4.11 Million | 4.23 Million | 1.56 Million | 2.96 Million | 4.9 Million |
| Capital Expenditure | - | - | -3803.00 | - | - | -53.31 Thousand |
| Effect of forex changes on cash | -2356.00 | 8266.00 | -13.42 Thousand | 4255.00 | -21.19 Thousand | 90.13 Thousand |
| Net cash flow / Change in cash | -1.28 Million | -127.78 Thousand | 2.66 Million | -1.39 Million | -1.94 Million | -1.95 Million |
| Free Cash Flow | -1.52 Million | -1.98 Million | -2.04 Million | -1.46 Million | -3.1 Million | -2.04 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -322.23 Thousand | -2.09 Million | -322.23 Thousand | -1.45 Million | -725.54 Thousand | -2.1 Million |
| Depreciation & Amortization | - | - | - | - | - | 557.00 |
| Deferred income taxes | - | - | - | - | - | 1250.00 |
| Stock-based compensation | 10.46 Thousand | - | 10.46 Thousand | 371.8 Thousand | 371.8 Thousand | -1250.00 |
| Change in working capital | -17.38 Thousand | -214.77 Thousand | -17.38 Thousand | - | - | 99.4 Thousand |
| Other non-cash items | 71.8 Thousand | 913.9 Thousand | 71.8 Thousand | 442.49 Thousand | -150.55 Thousand | 21.4 Thousand |
| Investing Cash Flow | 350 Thousand | -277.44 Thousand | 350 Thousand | -977.44 Thousand | -488.72 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -300 Thousand | -3.3 Million | - | -3 Million | - | - |
| Sales/Maturities of investments | 1 Million | 3.02 Million | - | 2.02 Million | - | - |
| Other Investing Activities | 350 Thousand | - | 350 Thousand | -488.72 Thousand | -488.72 Thousand | - |
| Financing Cash Flow | 1163.00 | 522.99 Thousand | 1163.00 | 520.66 Thousand | 260.33 Thousand | 1.85 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2326.00 | 522.99 Thousand | - | 520.66 Thousand | - | 1.85 Million |
| Other Financing Activities | 1163.00 | - | 1163.00 | 260.33 Thousand | 260.33 Thousand | -299.06 Thousand |
| Accounts receivables | 26.57 Thousand | 53.14 Thousand | 26.57 Thousand | - | - | -66.19 Thousand |
| Accounts payables | - | -180.01 Thousand | - | - | - | 156.07 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -43.95 Thousand | -87.9 Thousand | -43.95 Thousand | - | - | 9521.00 |
| Cash at beginning of period | 3.62 Million | 4.11 Million | - | 4.11 Million | - | 4.23 Million |
| Cash at end of period | 3.1 Million | 3.1 Million | 92.98 Thousand | 3.62 Million | -733.03 Thousand | 4.11 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -826.00 | - | -826.00 | -352.00 | -352.00 | 8266.00 |
| Net cash flow / Change in cash | -514.03 Thousand | -1 Million | 92.98 Thousand | -488.62 Thousand | -733.03 Thousand | -127.78 Thousand |
| Free Cash Flow | -257.35 Thousand | -1.52 Million | -257.35 Thousand | -1 Million | -504.29 Thousand | -1.98 Million |
GLAXF
STSB
7636
TPIC
002321
QEBR